Qigong for Breast Cancer Survivors' Cognitive Function
http://www.americantaichi.net/TaiChiQigongForHealthArticle.asp?cID=2&sID=60&article=chi_201809_4&subject=Other%20Health%20Topics The purpose of a new study done by University of Kansas was to evaluate the feasibility of an 8-week Qigong intervention to improve objectively and subjectively assessed cognitive function in breast cancer survivors who were 2 months to 8 years post completion of chemotherapy and radiation therapy. This research was published in August, 2018 by the
A Therapeutic Tai Chi Program: Optimal Choice for Falls Prevention
http://www.americantaichi.net/TaiChiQigongForHealthArticle.asp?cID=2&sID=7&article=chi_201809_1&subject=Falls%20Prevention Identifying optimal choices from among evidence-based fall prevention interventions is challenging as few comparative data for effectiveness are available. Oregon Research Institute led a cohort of medical research institutes to determine the effectiveness of a therapeutically tailored Tai Chi intervention, "Tai Ji Quan: Moving for Better Balance"(TJQMBB)
Qigong Helps Patients with Chronic Pain to Fight Substance Use Disorder
http://www.americantaichi.net/TaiChiQigongForHealthArticle.asp?cID=2&sID=4&article=chi_201808_3&subject=Pain Patients with chronic pain (CP) and substance use disorder (SUD) are complex, not yet adequately described, and in need of comprehensive treatments that address both diseases concurrently. The Pain Free Kids Foundation in California carried out a project to (a) describe a cohort of CP patients who failed traditional treatment (mainly opioids) - then developed opioid us
Effects of Tai Chi and Qigong on Major Depressive Disorder
http://www.americantaichi.net/TaiChiQigongForHealthArticle.asp?cID=2&sID=10&article=chi_201808_2&subject=Mental%20Health Tai Chi, Qigong, and Yoga are recognized as the most popular complementary approaches for alleviating musculoskeletal pain, improving sleep quality, and reducing blood pressure. The therapeutic effects of these meditative movements for treating major depressive disorder (MDD) are yet to be determined. In August, 2018, the Journal of clinical medicine report